17 National Congress of Iranian Pediatric Hematology & Oncology Society The Personalized Medicine and Immuno-Target Therapy in Childhood Malignancy
15-16 Jan 2025 (Hotel ERAM, Tehran)
|
Topic |
Expertise |
Image |
|
Welcome Message by a PHO Pioneer |
Prof. Mohammad Taghi Arzanian |
|
|
Welcome Message by the Head of IPHOS |
Prof. Hassan Abolghasemi |
|
|
Welcome Message by Scientific Secretary of the Congress |
Dr. Aziz Eghbali |
|
|
Precision Medicine:from NGS to Regenrative Medicine |
Dr. Davood Bashash |
|
|
CAR T CELL Therapy in Pediatric ALL |
Prof. Amirali Hamidieh |
|
|
The Importance of Molecular Testing in Childhood acute Leukemia |
Dr. Sudabeh Hosseini |
|
|
Special Considerations in MRD of Pediatric acute Leukemias Following Immunotherapy |
Dr. Behzad Poupak |
|
|
Prognostic Significance of MRD Befor and after HSCT in Childhood ALL |
Dr. Maryam Behfar |
|
|
Immunotherapy and Targeted Therapies in Pediatric ALL |
Prof. Mahshid Mehdizadeh |
|
|
The Role of Blinatumomab in the Treatment of acute Lymphoblastic Leukemia: A Study Report in Iran |
Dr. Aziz Eghbali |
|
|
Immunotherapy and Targeted Therapies in Pediatric AML |
Dr. Gholamreza Bahoush |
|
|
Discussion Panell in Childhood Acute Leukemias |
Prof. Mohammad Faranoosh Prof. Majid Naderi Prof. Ghasem Miri Prof. Mahshid Mehdizadeh Dr. Gholamreza Bahoush Dr. Aziz Eghbali (Manager) Dr. Fatemeh Malek |
|
|
Immunotherapy and Targeted Therapy in Neuroblastoma |
Prof. Samin Alavi |
|
|
Liquid Biopsy for Early Detection of Childhood Malignancy |
Prof. Mehdi Shahriari |
|
|
Histiocytosis Panell |
Prof. Bibi shahin Shamsian(Manager) Prof. Ashish R.Cumar (Cincinnati Children Hospital USA) Prof. Michael B.Jordan (Cincinnati Children Hospital USA) |
|
|
Case Presentation: LCH |
Prof. Bibi Shahin Shamsian |
|
|
Novel & Targeted Therapy in LCH |
Prof. Ashish R.Cumar (Cincinnati Children Hospital USA) |
|
|
Updates and Target Therapy in HLH |
Prof. Michael B.Jordan (Cincinnati Children Hospital USA) |
|
|
Novartis symposium title: Empowering Thalassemia Care |
Prof. Hassan Abolghasemi Prof. Bijan keikhaei Prof. Mohammad Faranoush Prof. Nargesbeygom Mirbehbahani Prof. Hossein Karami Dr. Seyed Omid Reza Zekavat Mr. Younes Arab |
|
|
Panel: Economic and policy challenges in providing immunotherapy drugs for pediatric cancers |
Prof. Hassan Abolghasemi(Manager) Prof. Mohammad Faranoosh Prof. Shahin Akhundzadeh_ Prof. Mahdi Pirsalehi_ Prof.Bibi Shahin Shamsian Dr. Davood Bashash |
|
|
The role of TKI in the Treatment of Pediatric Malignancies |
Prof. Mohammadreza Bordbar |
|
|
Vaccine_Based Immunotherapy in Solid Tumors |
Dr. Rohollah Dorostkar |
|
|
The role of Checkpoint Inhibitors in the Treatment of Pediatric Malignancies |
Dr. Mohammad Kazem Nourbakhsh |
|
|
The role of Exosomes in Pediatric Oncology |
Dr. Mahda Delshad |
|
|
Targeted Therapies in Brain Tumors |
Dr. Babak Abdolkarimi |
|
|
Immunotherapy in non-Hodgkin Lymphoma |
Dr. Parastoo Mollaei Tavana |
|
|
Immunotherapy in Hodgkin Lymphoma |
Dr. Neda Ashayeri |
|
|
Payk daru Scientific Program on the topic of: Introduction of some recently available drugs in childhood Hematology & Oncology |
Prof. Mohammad Faranoush Dr. Aziz Eghbali Dr. Sima Shokri |
|
|
Nivolumab Plus Ipilimumab in Children and Young Adults With Relapsed/Refractory Solid Tumors |
Dr. Amir Abbas Hedayati asl |
|
|
Precision Medicine, Future in HSCT era |
Dr. Hadi Mottaghi Pisheh |
|
|
Immunotherapy in Brain Glioma |
Dr. Azadeh Kioumarsi |
|
|
The Role of AI in Pediatric Malignancy |
Dr. Mostafa Ghaderzadeh |
|
|
The Role of NK Cells in the Treatment of Pediatric Malignancies |
Dr. Marzieh Ebrahimi |
|
